Oligonucleotide Synthesis Market

Home Healthcare And Pharmaceutical Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Services (Oligonucleotide Synthesis Products (Oligonucleotide Synthesis Equipment - Synthesizers, Oligonucleotide Synthesis Reagents & Consumables), Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, Small-Scale Oligonucleotide Synthesis); By Application (Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy (CpG Oligonucleotide-based Therapies), Nucleic Acid Aptamers), Diagnostics); By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published Date: January 2023
Report ID: BWC22580
Available Format: PDF
Page: 240

Report Overview

Rising autoimmune disease prevalence, expanding use of oligonucleotide synthesis, rising biosimilars' cost-effectiveness, rising government investments in healthcare infrastructure, and rising research and development capabilities could boost the growth of Global Oligonucleotide Synthesis Market during the forecast period between 2023 and 2029.

Global Oligonucleotide Synthesis Market - Industry Trends & Forecast Report, 2029

Global oligonucleotide synthesis market size is estimated at USD 5.99 billion in 2022. During the forecast period between 2023 and 2029, the size of global oligonucleotide synthesis market is projected to grow at a CAGR of 11.6% reaching a value of USD 12.94 billion by 2029. In research, genetic testing, drug development, and forensic applications, the demand for custom-made nucleotides for the desired sequence have increased due to the falling cost of sequencing. As a result, oligonucleotide synthesis is more in demand across a variety of life science applications. Numerous ongoing genetic research studies heavily rely on oligonucleotide synthesis. The demand for a custom synthesis of various classes of oligos, such as decoys, aptamers, immunostimulatory, antisense, siRNA, and miRNA, is expected to increase as genetic research funding increases. Several significant and up-and-coming producers of oligonucleotides are working with pharmaceutical manufacturers to expand their businesses. For instance, CordenPharma International and GE Healthcare Dharmacon Inc., signed a strategic collaboration agreement in June 2017 to develop an end-to-end oligonucleotide-based drug discovery solution.

Global Oligonucleotide Synthesis Market

Global Oligonucleotide Synthesis Market - Overview

Short nucleic acid fragments are joined together chemically in a process known as oligonucleotide synthesis to create desired sequenced products. Researchers can alter it by the application and their needs. It is utilized in recombinant DNA technologies to create monoclonal antibodies as primers and probes. Additionally, it is used for gene expression, cloning, molecular diagnostics, and screening for genetic diseases in biological, medical, forensic, and clinical applications. Additionally, it is becoming more popular in the therapeutic use of several medications because of the development of automated reactor platforms, which make oligonucleotides available at affordable prices.

Global Oligonucleotide Synthesis Market

Growth Drivers

Falling cost of sequencing driving oligonucleotide synthesis market

Over the last few years, advances in genomics research have resulted in a significant reduction in the cost of genome sequencing. NGS technology has significantly reduced the cost and increased the speed of DNA sequencing. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has dropped significantly from about USD 5 million in 2008 to about USD 1,000 in 2017. Sequencing is increasingly being used in genomics research not only to assemble genomes and investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology, and infectious diseases. As a result, the rapidly falling cost of sequencing is expected to boost research activities, fueling the demand for oligonucleotide synthesis products and technologies during the forecast period.

Significant opportunities in emerging Asian markets

For different market participants in the oligonucleotide synthesis industry, developed nations, such as the United States, have been the most important markets. But low-penetration emerging markets are expected to witness significant growth over the next few years due to an increase in oligonucleotide demand; R&D spending; proteomics, genomics, and metabolomics research; and in healthcare costs; and ongoing improvements in the healthcare system. For the past few years, market participants in the oligonucleotide synthesis industry have identified the Asia-Pacific region's emerging economies—including China, India, and Association of Southeast Asian Nations (ASEAN) members—as being particularly lucrative. The aging population, expanding healthcare system, and growing middle class in China are all contributing to the country's significant growth in the demand for genetic sequencing. For instance, in 2016, the Chinese Academy of Sciences introduced a USD 9.2-billion, 14-year project - The Precision Medicine Initiative - to sequence more than 100 million human genomes by 2030.

Restraints

In-house oligonucleotide development could affect growth of service providers

In-house oligonucleotide development has an impact on service providers' sales, according to a recent trend. Academic and research institutions are primarily responsible for this internal development. To maintain privacy and simplify manufacturing, biopharmaceutical companies have begun developing oligonucleotides themselves or have given contracts to other organizations. However, limited requirements and budgetary restrictions are impossible to monitor, which tends to reduce the market's potential. Due to a lack of resources, the global market may also experience growth restrictions. Research funding for academic laboratories is anticipated to be limited, which could restrain the growth of global oligonucleotide synthesis market. Additionally, some regions only have a small number of market participants, and there is a labor shortage. These elements might prevent the expansion of research activities in oligonucleotide synthesis.

Impact of COVID-19 on Global Oligonucleotide Synthesis Market

The newest novel coronavirus, COVID-19, is the infectious disease that it causes. Before the outbreak's start in Wuhan (China) in December 2019, COVID-19 was largely unknown. It became a global pandemic. The COVID-19 outbreak was formally classified as a pandemic by the World Health Organization (WHO). A variety of well-known pharmaceutical and biopharmaceutical firms stepped forward to support global research initiatives by offering oligo products for creating test kits, medications, and vaccines that target the infection caused by the novel Coronavirus. They joined forces with players in the oligonucleotide synthesis market. In April 2021, for example, Microsynth AG (Switzerland) provided key reagents, such as primer-probe sets to PCR testing labs to assist molecular diagnostic companies in developing and validating accurate, cutting-edge detection methods, as well as to provide comprehensive genomics expertise to research labs studying coronaviruses.

Global Oligonucleotide Synthesis Market

Segmental Coverage

Global Oligonucleotide Synthesis Market - By Product and Services

Global oligonucleotide synthesis market is divided into Oligonucleotide Synthesis Products - Oligonucleotide Synthesis Equipment (Synthesizers) and Oligonucleotide Synthesis Reagents & Consumables, Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, and Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, and Small-Scale Oligonucleotide Synthesis). The oligonucleotide synthesis products segment is expected to account for a significant market share in the oligonucleotide synthesis market. The widespread use of synthesizers and consumables, such as PCR primers in PCR studies, has resulted in a higher proportion of synthesis products. The widespread use of PCR technologies in research and diagnostic fields, owing to their ease of use, high sensitivity, and low cost, is fueling the segment growth.

Oligonucleotide Synthesis Market Share

Global Oligonucleotide Synthesis Market - By Application

On basis of the application, global oligonucleotide synthesis market is divided into Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, and Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy [CpG Oligonucleotide-based Therapies], and Nucleic Acid Aptamers), and Diagnostics. The research segment is expected to hold the highest market share in the global oligonucleotide synthesis market by application. However, due to the growing applications of molecular diagnostics (MDx) and genetic testing, the use of oligonucleotides for diagnostic applications is projected to grow at the fastest CAGR during the forecast period. For target screening and identification in drug development, PCR primers are frequently used. PCR primers currently hold the largest revenue share in the oligonucleotide synthesis market due to the presence of a strong pipeline of oligonucleotide-based therapeutics, including antisense therapeutics, DNA vaccines, and anti-viral agents, in various stages of clinical development.

Global Oligonucleotide Synthesis Market - By End User

On basis of end user, global oligonucleotide synthesis market is divided into Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, and other segments. Pharmaceutical and biotechnology companies are concentrating on finding alternative methods of treating diseases. As oligonucleotides provide an efficient mode of action for the treatment of a variety of indications at comparatively low development costs, these companies are heavily utilizing them. Additionally, oligonucleotides are crucial in resolving issues with the most effective drug administration route. The production of oligonucleotide therapeutics is then expected to rise, increasing the market share of pharmaceutical and biotechnology firms across countries. Infrastructure for education and research is being developed in emerging economies with funding from both public and private sources. This aspect is expected to encourage the use of oligonucleotides in academic research facilities.

Global Oligonucleotide Synthesis Market - By Region

Geographically, global oligonucleotide synthesis market covers five major markets: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to its rapid advancement in genomic studies, Asia Pacific is expected to record grow at the fastest rate with the rising adoption of sequencing, array technology, and PCR products. The most lucrative markets in the area for genomics investments are China and Japan. Additionally, it is expected that an increase in product launches and approvals will positively influence the market expansion. For instance, in December 2020, China approved the clinical use of Illumina's NextSeq 550Dx for use in genetic testing and diagnosis.

Competitive Landscape

Global oligonucleotide synthesis market is highly competitive. Prominent players in the market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, and Maravai LifeSciences. The key strategies used by these market leaders are new product launches, mergers & acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Recent Developments

In May 2022, Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science communities introduced new extra-large Drying Traps (up to 4 liters of acetonitrile solution) for research application. These new DNA moisture traps can be used for maintaining moisture-free environments in oligonucleotide synthesis.
In April 2022, Ansa Biotech raised USD 68 million to launch a customizable DNA synthesis service, stemming from the development of a novel synthesis method. The funds will support the company’s DNA synthesis research and development efforts.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period – 2023–2029
Facts Covered	Revenue in USD Billion
Market Coverage	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product/ Service Segmentation	Product & Services, Application, End User, Region
Key Players	Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, Maravai LifeSciences

By Product & Services

Oligonucleotide Synthesis Products

Oligonucleotide Synthesis Equipment (Synthesizers)
Oligonucleotide Synthesis Reagents & Consumables

Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)

Primers
Probes
Linkers & Adaptors

Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)

Large-Scale Oligonucleotide Synthesis
Intermediate-Scale Oligonucleotide Synthesis
Small-Scale Oligonucleotide Synthesis

By Application

Research

PCR
qPCR/RTqPCR
Sequencing
Gene Synthesis
Other Research Applications

Therapeutics

RNAi Oligonucleotide-based Therapies
DNA/Antisense oligonucleotide-based Therapies
Immunotherapy (CpG Oligonucleotide-based Therapies)
Nucleic Acid Aptamers

Diagnostics

By End User

Pharmaceutical and Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Oligonucleotide Synthesis Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Rising prevalence of autoimmune diseases
    2. Increasing adoption of Oligonucleotide Synthesis
    3. Growing number of cost-effective biosimilars
  2. Restraints
    1. Complexities in manufacturing
  3. Opportunities
    1. Rising research and development proficiencies
    2. Growing government investments on healthcare infrastructure
  4. Challenges
    1. Lack of standard protocols for developing software platforms
    2. Energy demand soars as EV sales soar
3. Product Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Oligonucleotide Synthesis Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Services
    1. Oligonucleotide Synthesis Products
      1. Oligonucleotide Synthesis Equipment (Synthesizers)
      2. Oligonucleotide Synthesis Reagents & Consumables
    2. Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
      1. Primers
      2. Probes
      3. Linkers & Adaptors
    3. Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)
      1. Large-Scale Oligonucleotide Synthesis
      2. Intermediate-Scale Oligonucleotide Synthesis
      3. Small-Scale Oligonucleotide Synthesis
  2. By Application
    1. Research
      1. PCR
      2. qPCR/RTqPCR
      3. Sequencing
      4. Gene Synthesis
      5. Other Research Applications
    2. Therapeutics
      1. RNAi Oligonucleotide-based Therapies
      2. DNA/Antisense oligonucleotide-based Therapies
      3. Immunotherapy (CpG Oligonucleotide-based Therapies)
      4. Nucleic Acid Aptamers
    3. Diagnostics
  3. By End User
    1. Pharmaceutical and Biotechnology Companies
    2. Academic & Research Institutes
    3. Diagnostic Laboratories
    4. Others
  4. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America
    5. Middle East and Africa (MEA)
North America Oligonucleotide Synthesis Market
1. 1. Market Size & Forecast, 2019–2029
  2. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Services
  2. By Application
  3. By End User
  4. By Country
    1. United States
      1. By Product & Services
      2. By Application
      3. By End User
    2. Canada
      1. By Product & Services
      2. By Application
      3. By End User
Europe Oligonucleotide Synthesis Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Services
  2. By Application
  3. By End User
  4. By Country
    1. Germany
      1. By Product & Services
      2. By Application
      3. By End User
    2. United Kingdom
      1. By Product & Services
      2. By Application
      3. By End User
    3. Italy
      1. By Product & Services
      2. By Application
      3. By End User
    4. France
      1. By Product & Services
      2. By Application
      3. By End User
    5. Spain
      1. By Product & Services
      2. By Application
      3. By End User
    6. The Netherlands
      1. By Product & Services
      2. By Application
      3. By End User
    7. Belgium
      1. By Product & Services
      2. By Application
      3. By End User
    8. NORDIC Countries
      1. By Product & Services
      2. By Application
      3. By End User
    9. Rest of Europe
      1. By Product & Services
      2. By Application
      3. By End User
Asia-Pacific Oligonucleotide Synthesis Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Services
  2. By Application
  3. By End User
  4. By Country
    1. China
      1. By Product & Services
      2. By Application
      3. By End User
    2. India
      1. By Product & Services
      2. By Application
      3. By End User
    3. Japan
      1. By Product & Services
      2. By Application
      3. By End User
    4. South Korea
      1. By Product & Services
      2. By Application
      3. By End User
    5. Australia & New Zealand
      1. By Product & Services
      2. By Application
      3. By End User
    6. Indonesia
      1. By Product & Services
      2. By Application
      3. By End User
    7. Malaysia
      1. By Product & Services
      2. By Application
      3. By End User
    8. Singapore
      1. By Product & Services
      2. By Application
      3. By End User
    9. Philippines
      1. By Product & Services
      2. By Application
      3. By End User
    10. Vietnam
      1. By Product & Services
      2. By Application
      3. By End User
    11. Rest of Asia Pacific
      1. By Product & Services
      2. By Application
      3. By End User
Latin America Oligonucleotide Synthesis Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product & Services
  2. By Application
  3. By End User
  4. By Country
    1. Brazil
      1. By Product & Services
      2. By Application
      3. By End User
    2. Mexico
      1. By Product & Services
      2. By Application
      3. By End User
    3. Argentina
      1. By Product & Services
      2. By Application
      3. By End User
    4. Peru
      1. By Product & Services
      2. By Application
      3. By End User
    5. Colombia
      1. By Product & Services
      2. By Application
      3. By End User
    6. Rest of Latin America
      1. By Product & Services
      2. By Application
      3. By End User
Middle East & Africa Oligonucleotide Synthesis Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product & Services
  2. By Application
  3. By End User
  4. By Country
    1. Saudi Arabia
      1. By Product & Services
      2. By Application
      3. By End User
    2. UAE
      1. By Product & Services
      2. By Application
      3. By End User
    3. Qatar
      1. By Product & Services
      2. By Application
      3. By End User
    4. Kuwait
      1. By Product & Services
      2. By Application
      3. By End User
    5. Iran
      1. By Product & Services
      2. By Application
      3. By End User
    6. South Africa
      1. By Product & Services
      2. By Application
      3. By End User
    7. Nigeria
      1. By Product & Services
      2. By Application
      3. By End User
    8. Kenya
      1. By Product & Services
      2. By Application
      3. By End User
    9. Egypt
      1. By Product & Services
      2. By Application
      3. By End User
    10. Morocco
      1. By Product & Services
      2. By Application
      3. By End User
    11. Algeria
      1. By Product & Services
      2. By Application
      3. By End User
    12. Rest of Middle East & Africa
      1. By Product & Services
      2. By Application
      3. By End User
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Essential Oils Company Market Share Analysis, 2021
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)
Impact of Covid-19 on Global Oligonucleotide Synthesis Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Thermo Fisher Scientific
2. Merck KGaA
3. GE Healthcare
4. Horizon Discovery Ltd.
5. Agilent Technologies
6. Kaneka Eurogentec S.A.
7. Integrated DNA Technologies, Inc.
8. LGC Biosearch Technologies
9. Eurofins Genomics
10. General Electric
11. Genscript
12. Danaher
13. TriLink BioTechnologies
14. Biolytic Lab Performance Inc.
15. PolyGen GmbH
16. Quintara Biosciences
17. Twist Bioscience
18. GENERI BIOTECH
19. Ionis Pharmaceuticals
20. Maravai LifeSciences
21. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

List of Figures

Figure 1 Global Oligonucleotide Synthesis Market Segmentation

Figure 2 Global Oligonucleotide Synthesis Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2021

Figure 4 Global Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 5 Global Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 6 Global Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 7 Global Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 8 Global Oligonucleotide Synthesis Market Share, By Region, By Value, 2019–2029

Figure 9 North America Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 10 North America Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 11 North America Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 12 North America Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 13 North America Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 14 United States Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 15 United States Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 16 United States Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 17 United States Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 18 Canada Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 19 Canada Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 20 Canada Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 21 Canada Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 22 Europe Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 23 Europe Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 24 Europe Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 25 Europe Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 26 Europe Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 27 Germany Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 28 Germany Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 29 Germany Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 30 Germany Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 31 UK Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 32 UK Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 33 UK Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 34 UK Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 35 Italy Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 36 Italy Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 37 Italy Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 38 Italy Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 39 France Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 40 France Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 41 France Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 42 France Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 43 Spain Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 44 Spain Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 45 Spain Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 46 Spain Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 47 The Netherlands Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 48 The Netherlands Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 49 The Netherlands Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 50 The Netherlands Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 51 Belgium Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 52 Belgium Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 53 Belgium Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 54 Belgium Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 55 NORDIC Countries Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 56 NORDIC Countries Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 57 NORDIC Countries Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 58 NORDIC Countries Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 59 Rest of Europe Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 60 Rest of Europe Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 61 Rest of Europe Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 62 Rest of Europe Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 63 Asia-Pacific Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 64 Asia-Pacific Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 65 Asia-Pacific Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 66 Asia-Pacific Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 67 Asia-Pacific Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 68 China Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 69 China Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 70 China Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 71 China Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 72 India Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 73 India Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 74 India Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 75 India Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 76 Japan Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 77 Japan Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 78 Japan Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 79 Japan Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 80 South Korea Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 81 South Korea Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 82 South Korea Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 83 South Korea Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 84 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 85 Australia & New Zealand Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 86 Australia & New Zealand Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 87 Australia & New Zealand Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 88 Indonesia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 89 Indonesia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 90 Indonesia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 91 Indonesia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 92 Malaysia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 93 Malaysia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 94 Malaysia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 95 Malaysia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 96 Singapore Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 97 Singapore Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 98 Singapore Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 99 Singapore Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 100 Philippines Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 101 Philippines Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 102 Philippines Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 103 Philippines Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 104 Vietnam Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 105 Vietnam Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 106 Vietnam Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 107 Vietnam Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 108 Rest of APAC Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 109 Rest of APAC Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 110 Rest of APAC Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 111 Rest of APAC Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 112 Latin America Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 113 Latin America Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 114 Latin America Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 115 Latin America Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 116 Latin America Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 117 Brazil Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 118 Brazil Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 119 Brazil Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 120 Brazil Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 121 Mexico Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 122 Mexico Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 123 Mexico Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 124 Mexico Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 125 Argentina Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 126 Argentina Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 127 Argentina Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 128 Argentina Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 129 Peru Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 130 Peru Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 131 Peru Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 132 Peru Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 133 Colombia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 134 Colombia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 135 Colombia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 136 Colombia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 137 Rest of LATAM Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 138 Rest of LATAM Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 139 Rest of LATAM Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 140 Rest of LATAM Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 141 Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 142 Middle East & Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 143 Middle East & Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 144 Middle East & Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 145 Middle East & Africa Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 146 Saudi Arabia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 147 Saudi Arabia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 148 Saudi Arabia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 149 Saudi Arabia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 150 UAE Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 151 UAE Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 152 UAE Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 153 UAE Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 154 Qatar Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 155 Qatar Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 156 Qatar Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 157 Qatar Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 158 Kuwait Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 159 Kuwait Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 160 Kuwait Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 161 Kuwait Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 162 Iran Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 163 Iran Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 164 Iran Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 165 Iran Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 166 South Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 167 South Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 168 South Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 169 South Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 170 Nigeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 171 Nigeria Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 172 Nigeria Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 173 Nigeria Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 174 Kenya Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 175 Kenya Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 176 Kenya Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 177 Kenya Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 178 Egypt Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 179 Egypt Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 180 Egypt Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 181 Egypt Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 182 Morocco Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 183 Morocco Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 184 Morocco Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 185 Morocco Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 186 Algeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 187 Algeria Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 188 Algeria Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 189 Algeria Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 190 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 191 Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 192 Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 193 Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

List of Tables

Table 1 Global Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 2 Global Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 3 Global Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 4 Global Oligonucleotide Synthesis Market Size, By Region, By Value, 2019–2029

Table 5 North America Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 6 North America Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 7 North America Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 8 North America Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 9 North America Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 10 United States Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 11 United States Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 12 United States Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 13 United States Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 14 Canada Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 15 Canada Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 16 Canada Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 17 Canada Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 18 Europe Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 19 Europe Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 20 Europe Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 21 Europe Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 22 Europe Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 23 Germany Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 24 Germany Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 25 Germany Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 26 Germany Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 27 UK Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 28 UK Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 29 UK Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 30 UK Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 31 Italy Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 32 Italy Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 33 Italy Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 34 Italy Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 35 France Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 36 France Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 37 France Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 38 France Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 39 Spain Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 40 Spain Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 41 Spain Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 42 Spain Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 43 The Netherlands Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 44 The Netherlands Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 45 The Netherlands Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 46 The Netherlands Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 47 Belgium Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 48 Belgium Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 49 Belgium Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 50 Belgium Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 51 NORDIC Countries Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 52 NORDIC Countries Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 53 NORDIC Countries Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 54 NORDIC Countries Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 55 Rest of Europe Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 56 Rest of Europe Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 57 Rest of Europe Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 58 Rest of Europe Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 59 Asia-Pacific Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 60 Asia-Pacific Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 61 Asia-Pacific Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 62 Asia-Pacific Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 63 Asia-Pacific Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 64 China Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 65 China Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 66 China Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 67 China Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 68 India Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 69 India Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 70 India Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 71 India Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 72 Japan Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 73 Japan Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 74 Japan Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 75 Japan Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 76 South Korea Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 77 South Korea Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 78 South Korea Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 79 South Korea Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 80 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 81 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 82 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 83 Australia & New Zealand Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 84 Indonesia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 85 Indonesia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 86 Indonesia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 87 Indonesia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 88 Malaysia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 89 Malaysia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 90 Malaysia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 91 Malaysia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 92 Singapore Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 93 Singapore Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 94 Singapore Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 95 Singapore Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 96 Philippines Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 97 Philippines Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 98 Philippines Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 99 Philippines Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 100 Vietnam Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 101 Vietnam Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 102 Vietnam Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 103 Vietnam Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 104 Rest of APAC Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 105 Rest of APAC Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 106 Rest of APAC Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 107 Rest of APAC Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 108 Latin America Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 109 Latin America Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 110 Latin America Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 111 Latin America Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 112 Latin America Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 113 Brazil Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 114 Brazil Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 115 Brazil Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 116 Brazil Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 117 Mexico Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 118 Mexico Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 119 Mexico Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 120 Mexico Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 121 Argentina Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 122 Argentina Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 123 Argentina Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 124 Argentina Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 125 Peru Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 126 Peru Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 127 Peru Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 128 Peru Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 129 Colombia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 130 Colombia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 131 Colombia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 132 Colombia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 133 Rest of LATAM Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 134 Rest of LATAM Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 135 Rest of LATAM Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 136 Rest of LATAM Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 137 Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 138 Middle East & Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 139 Middle East & Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 140 Middle East & Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 141 Middle East & Africa Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 142 Saudi Arabia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 143 Saudi Arabia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 144 Saudi Arabia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 145 Saudi Arabia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 146 UAE Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 147 UAE Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 148 UAE Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 149 UAE Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 150 Qatar Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 151 Qatar Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 152 Qatar Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 153 Qatar Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 154 Kuwait Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 155 Kuwait Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 156 Kuwait Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 157 Kuwait Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 158 Iran Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 159 Iran Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 160 Iran Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 161 Iran Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 162 South Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 163 South Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 164 South Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 165 South Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 166 Nigeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 167 Nigeria Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 168 Nigeria Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 169 Nigeria Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 170 Kenya Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 171 Kenya Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 172 Kenya Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 173 Kenya Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 174 Egypt Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 175 Egypt Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 176 Egypt Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 177 Egypt Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 178 Morocco Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 179 Morocco Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 180 Morocco Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 181 Morocco Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 182 Algeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 183 Algeria Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 184 Algeria Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 185 Algeria Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 186 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 187 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 188 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 189 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 190 Thermo Fisher Scientific Company Overview

Table 191 Thermo Fisher Scientific Financial Overview

Table 192 Merck KGaA Company Overview

Table 193 Merck KGaA Financial Overview

Table 194 GE Healthcare Company Overview

Table 195 GE Healthcare Financial Overview

Table 196 Horizon Discovery Ltd. Company Overview

Table 197 Horizon Discovery Ltd. Financial Overview

Table 198 Agilent Technologies Company Overview

Table 199 Agilent Technologies Financial Overview

Table 200 Kaneka Eurogentec S.A. Company Overview

Table 201 Kaneka Eurogentec S.A. Financial Overview

Table 202 Integrated DNA Technologies, Inc. Company Overview

Table 203 Integrated DNA Technologies, Inc. Financial Overview

Table 204 LGC Biosearch Technologies Company Overview

Table 205 LGC Biosearch Technologies Financial Overview

Table 206 Eurofins Genomics Company Overview

Table 207 Eurofins Genomics Financial Overview

Table 208 General Electric Company Overview

Table 209 General Electric Financial Overview

Table 210 Genscript Company Overview

Table 211 Genscript Financial Overview

Table 212 Danaher Company Overview

Table 213 Danaher Financial Overview

Table 214 TriLink BioTechnologies Company Overview

Table 215 TriLink BioTechnologies Financial Overview

Table 216 Biolytic Lab Performance Inc. Company Overview

Table 217 Biolytic Lab Performance Inc. Financial Overview

Table 218 PolyGen GmbH Company Overview

Table 219 PolyGen GmbH Financial Overview

Table 220 Quintara Biosciences Company Overview

Table 221 Quintara Biosciences Financial Overview

Table 222 Twist Bioscience Company Overview

Table 223 Twist Bioscience Financial Overview

Table 224 GENERI BIOTECH Company Overview

Table 225 GENERI BIOTECH Financial Overview

Table 226 Ionis Pharmaceuticals Company Overview

Table 227 Ionis Pharmaceuticals Financial Overview

Table 228 Maravai LifeSciences Company Overview

Table 229 Maravai LifeSciences Financial Overview

Market Segmentation

By Product & Services

Oligonucleotide Synthesis Products

Oligonucleotide Synthesis Equipment (Synthesizers)
Oligonucleotide Synthesis Reagents & Consumables

Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)

Primers
Probes
Linkers & Adaptors

Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)

Large-Scale Oligonucleotide Synthesis
Intermediate-Scale Oligonucleotide Synthesis
Small-Scale Oligonucleotide Synthesis

By Application

Research

PCR
qPCR/RTqPCR
Sequencing
Gene Synthesis
Other Research Applications

Therapeutics

RNAi Oligonucleotide-based Therapies
DNA/Antisense oligonucleotide-based Therapies
Immunotherapy (CpG Oligonucleotide-based Therapies)
Nucleic Acid Aptamers

Diagnostics

By End User

Pharmaceutical and Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What are the major factors driving the growth of Global Oligonucleotide Synthesis Market?

Ans: Major factors driving the growth of Global Oligonucleotide Synthesis Market include rising autoimmune disease prevalence, expanding use of oligonucleotide synthesis, rising biosimilars' cost-effectiveness, rising government investments in healthcare infrastructure, and rising research and development capabilities.

2. What is the current market size of Global Oligonucleotide Synthesis Market?

Ans: Global Oligonucleotide Synthesis Market size is estimated at 5.99 billion in 2022.

3. Which end-user segment is the dominant one in Global Oligonucleotide Synthesis Market

Ans: The pharmaceutical and biotechnology companies segment holds the highest market share in Global Oligonucleotide Synthesis Market.

4. Which product and services segment accounts for the highest market share in Global Oligonucleotide Synthesis Market?

Ans: The oligonucleotide synthesis segment accounted for the highest market share in Global Oligonucleotide Synthesis Market.

5. Name the key players in Global Oligonucleotide Synthesis Market.

Ans: Key players in Global Oligonucleotide Synthesis Market include Thermo Fisher Scientific, Merck KgaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, and Maravai LifeSciences.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4450
GROUP LICENSE
$ 5550
ENTERPRISE LICENSE
$ 7850

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.